Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on July 11, 2024, by Catheter Precision, Inc., a Delaware corporation. The report details the implementation of a reverse stock split and a reduction in authorized common stock, actions previously approved by stockholders at the Annual Meeting held on July 3, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The primary quantitative data relates to capital structure adjustments:
- Pre-Split Outstanding Shares: Approximately 9,012,518
- Post-Split Outstanding Shares: Approximately 901,251
- Reverse Split Ratio: 1-for-10
- Authorized Share Reduction: From 300 million to 30 million shares
Material Changes Versus Prior Period
The material change reported is the amendment to the Company's Restated Certificate of Incorporation. This amendment effects a 1-for-10 reverse stock split and reduces the authorized share count. The split is designed to increase the per-share trading price and reduce the total number of outstanding shares without altering any stockholder's percentage ownership interest, except for immaterial changes due to fractional share treatment.
Guidance, Outlook, and Unusual Items
The filing contains no financial guidance, outlook, or management commentary regarding future operating performance. Key operational details regarding the corporate action include:
- Effective Date: The Charter Amendment becomes effective at 12:01 a.m. Eastern Time on July 15, 2024.
- Trading Resumption: Common stock will begin trading on a split-adjusted basis on July 15, 2024, under the existing symbol "VTAK" with a new CUSIP number (74933X 609).
- Fractional Shares: No fractional shares will be issued; holders entitled to fractions will receive cash proceeds from the sale of aggregated fractional shares.
- Adjustments: Exercise prices and share counts for outstanding stock options, warrants, and preferred stock conversion ratios will be proportionately adjusted.
Investor Verification Checklist
- Verify the new CUSIP number (74933X 609) for trading purposes on July 15, 2024.
- Confirm the exact number of shares held post-split, noting that fractional shares are converted to cash.
- Review the impact of the 1-for-10 split on the exercise price and share count of any held stock options or warrants.
- Monitor the stock price performance on the NYSE American following the split to assess liquidity and compliance with exchange listing standards.